Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan Rolland

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Annals of Surgical Oncology|March 16, 2013
Volumetric changes after (90)y radioembolization for hepatocellular carcinoma in cirrhosis: an option to portal vein embolization in a preoperative setting?Julien Edeline, Laurence Lenoir, Karim Boudjema, et al.
Cancers|May 16, 2023
<sup>188</sup>Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study)Etienne Garin, Xavier Palard, Yan Rolland, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 12, 2016
High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with <sup>90</sup> Y-loaded glass microsphere radioembolizationEtienne Garin, Yan Rolland, Marc Pracht, et al.
Clinical Nuclear Medicine|July 24, 2015
Glass Microspheres 90Y Selective Internal Radiation Therapy and Chemotherapy as First-Line Treatment of Intrahepatic CholangiocarcinomaJulien Edeline, Fanny Le Du, Michel Rayar, et al.
European Journal of Gastroenterology & Hepatology|July 20, 2021
Selective internal radiation therapy in older patients with hepatocellular carcinoma: a retrospective analysisSoraya Benguerfi, Florian Estrade, Céline Lescure, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2019
Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with <sup>188</sup>Re-SSS Lipiodol radioembolizationKostas Delaunay, Julien Edeline, Yan Rolland, et al.
Medical & Biological Engineering & Computing|August 22, 2017
Towards a patient-specific hepatic arterial modeling for microspheres distribution optimization in SIRT protocolCostanza Simoncini, Krzysztof Jurczuk, Daniel Reska, et al.
Hepatology (Baltimore, Md.)|July 28, 2023
Chemotherapy with or without selective internal radiation therapy for intrahepatic cholangiocarcinoma: Data from clinical trialsJulien Edeline, John Bridgewater, Boris Campillo-Gimenez, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 28, 2016
Haralick textural features on T<sub>2</sub> -weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancerKhémara Gnep, Auréline Fargeas, Ricardo E Gutiérrez-Carvajal, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2010
Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphomaLudovic Le Dortz, Sophie De Guibert, Sahar Bayat, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Annals of Surgical Oncology|March 16, 2013
Volumetric changes after (90)y radioembolization for hepatocellular carcinoma in cirrhosis: an option to portal vein embolization in a preoperative setting?Julien Edeline, Laurence Lenoir, Karim Boudjema, et al.
Cancers|May 16, 2023
<sup>188</sup>Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study)Etienne Garin, Xavier Palard, Yan Rolland, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 12, 2016
High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with <sup>90</sup> Y-loaded glass microsphere radioembolizationEtienne Garin, Yan Rolland, Marc Pracht, et al.
Clinical Nuclear Medicine|July 24, 2015
Glass Microspheres 90Y Selective Internal Radiation Therapy and Chemotherapy as First-Line Treatment of Intrahepatic CholangiocarcinomaJulien Edeline, Fanny Le Du, Michel Rayar, et al.
European Journal of Gastroenterology & Hepatology|July 20, 2021
Selective internal radiation therapy in older patients with hepatocellular carcinoma: a retrospective analysisSoraya Benguerfi, Florian Estrade, Céline Lescure, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2019
Preliminary results of the Phase 1 Lip-Re I clinical trial: biodistribution and dosimetry assessments in hepatocellular carcinoma patients treated with <sup>188</sup>Re-SSS Lipiodol radioembolizationKostas Delaunay, Julien Edeline, Yan Rolland, et al.
Medical & Biological Engineering & Computing|August 22, 2017
Towards a patient-specific hepatic arterial modeling for microspheres distribution optimization in SIRT protocolCostanza Simoncini, Krzysztof Jurczuk, Daniel Reska, et al.
Hepatology (Baltimore, Md.)|July 28, 2023
Chemotherapy with or without selective internal radiation therapy for intrahepatic cholangiocarcinoma: Data from clinical trialsJulien Edeline, John Bridgewater, Boris Campillo-Gimenez, et al.
Journal of Magnetic Resonance Imaging : JMRI|June 28, 2016
Haralick textural features on T<sub>2</sub> -weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancerKhémara Gnep, Auréline Fargeas, Ricardo E Gutiérrez-Carvajal, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2010
Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphomaLudovic Le Dortz, Sophie De Guibert, Sahar Bayat, et al.
Pageof 7